UCP2 and breast cancer: Here we report for the first time that UCP-2 overexpression was induced by HER2 phosphorylation in HER2-positive breast cancer, and this could be reversed by HER2 kinase inhibitor ONT-380, indicating potential signaling regulation of UCP-2 expression by HER2 phosphorylation.